share_log

B of A Securities Upgrades Sabra Health Care REIT to Neutral, Raises Price Target to $14

B of A Securities Upgrades Sabra Health Care REIT to Neutral, Raises Price Target to $14

B of A Securities将Sabra Health Care REIT上调至中性,将目标股价上调至14美元
Benzinga ·  2023/08/11 09:15

B of A Securities analyst Joshua Dennerlein upgrades Sabra Health Care REIT (NASDAQ:SBRA) from Underperform to Neutral and raises the price target from $11 to $14.

美国银行证券分析师Joshua Dennerlein将Sabra Health Care REIT(纳斯达克:SBRA)从表现不佳上调至中性,并将目标价从11美元上调至14美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发